高甘油三酯血症性胰腺炎的研究进展
Research Progress of Hypertriglyceridemic Pancreatitis
DOI: 10.12677/ACM.2024.143755, PDF,   
作者: 王冠伦, 常家乐:内蒙古医科大学研究生院,内蒙古 呼和浩特;王万祥*, 杨 帆:内蒙古医科大学附属医院肝胆胰脾外科,内蒙古 呼和浩特
关键词: 高甘油三酯血症急性胰腺炎肝素血浆置换 Hypertriglyceridemia Acute Pancreatitis Heparin Plasma Exchange
摘要: 高甘油三酯血症(Hypertriglyceridemia, HTG)是急性胰腺炎(Acute Pancreatitis, AP)的一个不常见但已确定的原因之一,占7%。HTG诱发的胰腺炎(HTG-induced Pancreatitis, HTGP)的临床过程与其他病因的AP非常相似,但HTG是唯一的临床特征。然而,HTGP往往有较高的严重程度和并发症发生率。尽管胰岛素、肝素和omega-3脂肪酸等不同的治疗方式已成功地用于降低血清甘油三酯(Triglycerides, TG),但目前尚无可供选择的治疗指南。血浆置换术也被用来抵消HTGP患者中升高的TG水平。在处理急性期后,改变生活方式包括饮食调整和药物治疗对HTGP的长期管理和预防复发至关重要。现有研究结果不足以得出坚实的结论,导致HTGP没有有效管理策略。因此,未来需要进一步前瞻性、随机对照的临床研究来寻找更好的治疗方案。
Abstract: HTG (Hypertriglyceridemia) is an uncommon but identified cause of AP (acute pancreatitis), ac-counting for 7%. The clinical process of HTGP (HTG-induced pancreatitis) is very similar to AP of other causes, but HTG is the only clinical feature. However, HTGP often has a high severity and inci-dence of complications. Although different treatments such as insulin, heparin and omega-3 fatty acids have been successfully used to reduce serum TG (triglycerides), there are no alternative treatment guidelines. Plasma exchange is also used to counteract elevated TG levels in patients with HTGP. After dealing with the acute phase, lifestyle changes, including diet adjustment and drug treatment, are essential for the long-term management and prevention of recurrence of HTGP. The existing research results are not enough to draw a solid conclusion, resulting in no effective man-agement strategy for HTGP. Therefore, further prospective, randomized controlled clinical studies are needed to find a better treatment in the future.
文章引用:王冠伦, 王万祥, 常家乐, 杨帆. 高甘油三酯血症性胰腺炎的研究进展[J]. 临床医学进展, 2024, 14(3): 670-675. https://doi.org/10.12677/ACM.2024.143755

参考文献

[1] Xiao, A.Y., Tan, M.L., Wu, L.M., et al. (2016) Global Incidence and Mortality of Pancreatic Diseases: A Systematic Re-view, Meta-Analysis, and Meta-Regression of Population-Based Cohort Studies. The Lancet Gastroenterology and Hepatology, 1, 45-55. [Google Scholar] [CrossRef
[2] Rawla, P., Bandaru, S.S. and Vellipu-ram, A.R. (2017) Review of Infectious Etiology of Acute Pancreatitis. Gastroenterology Research, 10, 153-158. [Google Scholar] [CrossRef] [PubMed]
[3] Carr, R.A., Rejowski, B.J., Cote, G.A., et al. (2016) Systematic Review of Hypertriglyceridemia-Induced Acute Pancreatitis: A More Virulent Etiology? Pancreatology, 16, 469-476. [Google Scholar] [CrossRef] [PubMed]
[4] Kota, S.K., Kota, S.K., Jammula, S., et al. (2012) Hypertriglycer-idemia-Induced Recurrent Acute Pancreatitis: A Case-Based Review. Indian Journal of Endocrinology and Metabolism, 16, 141-143. [Google Scholar] [CrossRef] [PubMed]
[5] Adiamah, A., Psaltis, E., Crook, M., et al. (2018) A Systematic Re-view of the Epidemiology, Pathophysiology and Current Management of Hyperlipidaemic Pancreatitis. Clinical Nutrition, 37, 1810-1822. [Google Scholar] [CrossRef] [PubMed]
[6] Anderson, F., Thomson, S.R., Clarke, D.L., et al. (2009) Dyslipi-daemic Pancreatitis Clinical Assessment and Analysis of Disease Severity and Outcomes. Pancreatology, 9, 252-257. [Google Scholar] [CrossRef] [PubMed]
[7] Garg, R. and Rustagi, T. (2018) Management of Hypertriglyceridemia In-duced Acute Pancreatitis. BioMed Research International, 2018, Article ID: 4721357. [Google Scholar] [CrossRef] [PubMed]
[8] Banks, P.A., Bollen, T.L., Dervenis, C., et al. (2013) Classification of Acute Pancreatitis-2012: Revision of the Atlanta Classification and Definitions by International Consensus. Gut, 62, 102-111. [Google Scholar] [CrossRef] [PubMed]
[9] Zarnescu, N.O., Barbu, S.T., Zarnescu Vasiliu, E.C., et al. (2015) Management of Acute Pancreatitis in the Early Stage. Maedica (Bucur), 10, 257-263.
[10] Wang, L., Xu, T., Wang, R., et al. (2022) Hypertriglyceridemia Acute Pancreatitis: Animal Experiment Research. Digestive Diseases and Sciences, 67, 761-772. [Google Scholar] [CrossRef] [PubMed]
[11] Tenner, S., Baillie, J., Dewitt, J., et al. (2013) Ameri-can College of Gastroenterology Guideline: Management of Acute Pancreatitis. American Journal of Gastroenterology, 108, 1400-1416. [Google Scholar] [CrossRef] [PubMed]
[12] Khan, R., Jehangir, W., Regeti, K., et al. (2015) Hyper-triglyceridemia-Induced Pancreatitis: Choice of Treatment. Gastroenterology Research, 8, 234-236. [Google Scholar] [CrossRef] [PubMed]
[13] Coskun, A., Erkan, N., Yakan, S., et al. (2015) Treatment of Hypertriglycer-idemia-Induced Acute Pancreatitis with Insulin. Przegla̜d Gastroenterologiczny, 10, 18-22. [Google Scholar] [CrossRef] [PubMed]
[14] Scherer, J., Singh, V.P., Pitchumoni, C.S., et al. (2014) Issues in Hy-pertriglyceridemic Pancreatitis: An Update. Journal of Clinical Gastroenterology, 48, 195-203. [Google Scholar] [CrossRef] [PubMed]
[15] Goldberg, I.J. (1996) Lipoprotein Lipase and Lipolysis: Central Roles in Lipoprotein Metabolism and Atherogenesis. Journal of Lipid Research, 37, 693-707. [Google Scholar] [CrossRef
[16] Afari, M.E., Shafqat, H., Shafi, M., et al. (2015) Hypertri-glyceridemia-Induced Pancreatitis: A Decade of Experience in a Community-Based Teaching Hospital. Rhode Island Medical Journal (2013), 98, 40-43.
[17] Thuzar, M., Shenoy, V.V., Malabu, U.H., et al. (2014) Extreme Hypertriglyc-eridemia Managed with Insulin. Journal of Clinical Lipidology, 8, 630-634. [Google Scholar] [CrossRef] [PubMed]
[18] Gray, E., Hogwood, J. and Mulloy, B. (2012) The Anticoagulant and Antithrombotic Mechanisms of Heparin. In: Lever, R., Mulloy, B. and Page, C.P., Eds., Heparin—A Century of Progress, Vol. 207, Springer, Berlin, 43-61. [Google Scholar] [CrossRef] [PubMed]
[19] Korn, E.D. (1955) Clearing Factor, a Heparin-Activated Lipo-protein Lipase. I. Isolation and Characterization of the Enzyme from Normal Rat Heart. Journal of Biological Chemistry, 215, 1-14. [Google Scholar] [CrossRef
[20] Kuchay, M.S., Farooqui, K.J., Bano, T., et al. (2017) Hepa-rin and Insulin in the Management of Hypertriglyceridemia-Associated Pancreatitis: Case Series and Literature Review. Archives of Endocrinology and Metabolism, 61, 198-201. [Google Scholar] [CrossRef] [PubMed]
[21] Henzen, C., Röck, M., Schnieper, C., et al. (1999) Heparin and Insulin in the Treatment of Acute Hypertriglyceridemia-Induced Pancreatitis. Schweizerische Medizinische Wochenschrift, 129, 1242-1248.
[22] Jain, D. and Zimmerschied, J. (2009) Heparin and Insulin for Hypertriglyceridemia-Induced Pan-creatitis: Case Report. Scientific World Journal, 9, 1230-1232. [Google Scholar] [CrossRef] [PubMed]
[23] Click, B., Ketchum, A.M., Turner, R., et al. (2015) The Role of Apheresis in Hypertriglyceridemia-Induced Acute Pancreatitis: A Systematic Review. Pancreatology, 15, 313-320. [Google Scholar] [CrossRef] [PubMed]
[24] He, W.H., Yu, M., Zhu, Y., et al. (2016) Emergent Triglyceride-Lowering Therapy with Early High-Volume Hemofiltration against Low-Molecular-Weight Heparin Combined with Insulin in Hypertriglyceridemic Pancreatitis: A Prospective Randomized Controlled Trial. Journal of Clinical Gastroenterology, 50, 772-778. [Google Scholar] [CrossRef
[25] Miyamoto, K., Horibe, M., Sanui, M., et al. (2017) Plas-mapheresis Therapy Has No Triglyceride-Lowering Effect in Patients with Hypertriglyceridemic Pancreatitis. Intensive Care Medicine, 43, 949-951. [Google Scholar] [CrossRef] [PubMed]
[26] Kris-Etherton, P.M., Pearson, T.A., Wan, Y., et al. (1999) High-Monounsaturated Fatty Acid Diets Lower Both Plasma Cholesterol and Triacylglycerol Concentrations. The Amer-ican Journal of Clinical Nutrition, 70, 1009-1015. [Google Scholar] [CrossRef] [PubMed]
[27] Christian, J.B., Arondekar, B., Buysman, E.K., et al. (2012) Clinical and Economic Benefits Observed When Follow-Up Triglyceride Levels Are Less than 500 Mg/DL in Patients with Se-vere Hypertriglyceridemia. Journal of Clinical Lipidology, 6, 450-461. [Google Scholar] [CrossRef] [PubMed]
[28] (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 285, 2486-2497. [Google Scholar] [CrossRef] [PubMed]
[29] Keller, D., Hardin, E.M., Nagula, S.V., et al. (2022) Hypertriglyc-eridemia-Induced Acute Pancreatitis during Pregnancy: A Case Report. Cureus, 14, E28273. [Google Scholar] [CrossRef] [PubMed]
[30] Grisham, J.M., Tran, A.H. and Ellery, K. (2022) Hypertriglyceridem-ia-Induced Acute Pancreatitis in Children: A Mini-Review. Frontiers in Pediatrics, 10, Article ID: 931336. [Google Scholar] [CrossRef] [PubMed]
[31] Goraya, M.H.N., Abbasi, E.U.H., Amin, M.K., et al. (2023) Acute Pancreatitis Secondary to Tamoxifen-Associated Hypertriglyceridemia: A Clinical Update. Journal of Oncology Phar-macy Practice, 29, 218-225. [Google Scholar] [CrossRef] [PubMed]